116 related articles for article (PubMed ID: 24067866)
1. Improved therapeutic effect on malignant glioma with adenoviral suicide gene therapy combined with temozolomide.
Stedt H; Samaranayake H; Pikkarainen J; Määttä AM; Alasaarela L; Airenne K; Ylä-Herttuala S
Gene Ther; 2013 Dec; 20(12):1165-71. PubMed ID: 24067866
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma.
Rainov NG; Fels C; Droege JW; Schäfer C; Kramm CM; Chou TC
Cancer Gene Ther; 2001 Sep; 8(9):662-8. PubMed ID: 11593335
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S
Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830
[TBL] [Abstract][Full Text] [Related]
4. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
5. Polyamine biosynthesis inhibition enhances HSV-1 thymidine kinase/ganciclovir-mediated cytotoxicity in tumor cells.
Pasanen T; Karppinen A; Alhonen L; Jänne J; Wahlfors J
Int J Cancer; 2003 Apr; 104(3):380-8. PubMed ID: 12569563
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions.
Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S
Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
[TBL] [Abstract][Full Text] [Related]
8. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy.
LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV
Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410
[TBL] [Abstract][Full Text] [Related]
9. Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment.
Sandmair AM; Loimas S; Poptani H; Vainio P; Vanninen R; Turunen M; Tyynelä K; Vapalahti M; Ylä-Herttuala S
Acta Neurochir (Wien); 1999; 141(8):867-72; discussion 872-3. PubMed ID: 10536724
[TBL] [Abstract][Full Text] [Related]
10. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
11. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
13. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
14. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
15. Increased invasion of malignant gliomas after 15-LO-1 and HSV-tk/ganciclovir combination gene therapy.
Pacholska A; Wirth T; Samaranayake H; Pikkarainen J; Ahmad F; Ylä-Herttuala S
Cancer Gene Ther; 2012 Dec; 19(12):870-4. PubMed ID: 23079672
[TBL] [Abstract][Full Text] [Related]
16. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo.
Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S
Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181
[TBL] [Abstract][Full Text] [Related]
17. An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment.
Kostova Y; Mantwill K; Holm PS; Anton M
Cancer Gene Ther; 2015 Jan; 22(1):30-43. PubMed ID: 25501992
[TBL] [Abstract][Full Text] [Related]
18. Tomato thymidine kinase-based suicide gene therapy for malignant glioma--an alternative for Herpes Simplex virus-1 thymidine kinase.
Stedt H; Samaranayake H; Kurkipuro J; Wirth G; Christiansen LS; Vuorio T; Määttä AM; Piškur J; Ylä-Herttuala S
Cancer Gene Ther; 2015 Apr; 22(3):130-7. PubMed ID: 25613481
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of tumor ablation by a selected HSV-1 thymidine kinase mutant.
Kokoris MS; Sabo P; Adman ET; Black ME
Gene Ther; 1999 Aug; 6(8):1415-26. PubMed ID: 10467366
[TBL] [Abstract][Full Text] [Related]
20. Imaging progress of herpes simplex virus type 1 thymidine kinase suicide gene therapy in living subjects with positron emission tomography.
Yaghoubi SS; Barrio JR; Namavari M; Satyamurthy N; Phelps ME; Herschman HR; Gambhir SS
Cancer Gene Ther; 2005 Mar; 12(3):329-39. PubMed ID: 15592447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
